PhaseBio Pharmaceuticals, Inc. PHAS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 PhaseBio Pharmaceuticals, Inc. (PHAS), 포함 35 건 매수 및 13 건 매도. 내부자 매수 총액은 $1.07M 내부자 매도 총액은 $421.77K.

최근 활동이 있는 주요 내부자에는 Harrigan Edmund, Loewy Caroline M, Hutson Nancy J. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — PHAS

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2023-05-19	Harrigan Edmund	Director	옵션 행사	3,750	-	-	-
2023-05-19	Loewy Caroline M	Director	옵션 행사 (매도)	3,750	-	-	-
2023-05-19	Hutson Nancy J	Director	옵션 행사 (매도)	3,750	-	-	-
2023-05-19	Van Den Broek Richard	Director	옵션 행사 (매도)	3,750	-	-	-
2023-05-19	Thorp Clay	Director	옵션 행사	3,750	-	-	-
2023-05-19	Humphries William D.	Director	옵션 행사 (매도)	2,538	-	-	-
2023-05-19	Sapir Alex	Director	옵션 행사 (매도)	3,750	-	-	-
2022-10-25	New Enterprise Associates 13 Lp	Director	정보 매도	1,784,109	$0.15	$262.26K	4,857,525
2022-05-20	Mow Jonathan P	Chief Executive Officer	RSU 부여	10,918	$0.68	$7.44K	132,502
2022-05-20	Sharp John P	Chief Financial Officer	RSU 부여	6,026	$0.68	$4.11K	65,767
2022-05-20	Arnold Susan Elizabeth	SVP, Technical Operations	RSU 부여	10,917	$0.68	$7.44K	41,236
2022-05-20	Hanson Kristopher	SVP and General Counsel	RSU 부여	4,831	$0.68	$3.29K	8,463
2022-05-20	Burkhardt Glen	SVP of Human Resources	정보 매도	11,248	$0.79	$8.89K	-
2022-05-20	Birchall Jonathan	Chief Commercial Officer	RSU 부여	20,000	$0.68	$13.63K	20,000
2022-05-19	Harrigan Edmund	Director	RSU 부여	3,750	-	-	3,750
2022-05-19	Loewy Caroline M	Director	RSU 부여	3,750	-	-	3,750
2022-05-19	Hutson Nancy J	Director	RSU 부여	3,750	-	-	3,750
2022-05-19	Van Den Broek Richard	Director	RSU 부여	3,750	-	-	3,750
2022-05-19	Thorp Clay	Director	RSU 부여	3,750	-	-	3,750
2022-05-19	Humphries William D.	Director	RSU 부여	3,750	-	-	3,750
2022-05-19	Sapir Alex	Director	RSU 부여	3,750	-	-	3,750
2022-05-19	Humphries William D.	Director	RSU 부여	2,538	-	-	2,538
2022-02-24	Mow Jonathan P	Chief Executive Officer	RSU 부여	82,500	-	-	82,500
2022-02-24	Sharp John P	Chief Financial Officer	RSU 부여	24,750	-	-	24,750
2022-02-24	Lee John Sang	Chief Medical Officer	RSU 부여	24,750	-	-	24,750
2022-02-24	Arnold Susan Elizabeth	SVP, Technical Operations	RSU 부여	18,750	-	-	18,750
2022-02-24	Hanson Kristopher	VP, Head of Legal	RSU 부여	18,750	-	-	18,750
2022-02-24	Burkhardt Glen	VP, Human Resources	RSU 부여	18,750	-	-	18,750
2022-02-24	Birchall Jonathan	Chief Commercial Officer	RSU 부여	11,250	-	-	11,250
2021-11-19	Mow Jonathan P	Chief Executive Officer	RSU 부여	5,623	$2.01	$11.3K	172,473
2021-11-19	Sharp John P	Chief Financial Officer	RSU 부여	2,017	$2.01	$4.05K	59,741
2021-11-19	Arnold Susan Elizabeth	SVP, Technical Operations	RSU 부여	2,559	$2.01	$5.14K	30,319
2021-11-19	Hanson Kristopher	VP, Head of Legal	RSU 부여	1,545	$2.01	$3.11K	3,632
2021-11-19	Burkhardt Glen	VP, Human Resources	정보 매도	5,766	$2.37	$13.67K	-
2021-11-08	Hutson Nancy J	Director	옵션 행사 (매도)	7,400	$3.15	$23.31K	-
2021-11-08	Birchall Jonathan	Officer	알 수 없음	-	-	-	-
2021-11-08	Birchall Jonathan	Chief Commercial Officer	RSU 부여	250,000	$3.37	$842.5K	250,000
2021-11-05	Hutson Nancy J	Director	옵션 행사 (매도)	24,860	$2.26	$56.18K	2,256
2021-11-03	Mow Jonathan P	Chief Executive Officer	옵션 행사 (매도)	20,000	$1.24	$24.8K	108,767
2021-11-03	Sharp John P	Chief Financial Officer	옵션 행사	7,500	$1.68	$12.6K	57,724
2021-09-14	Humphries William D.	Director	알 수 없음	-	-	-	-
2021-09-14	Humphries William D.	Director	RSU 부여	28,000	$2.80	$78.4K	28,000
2021-08-27	Mow Jonathan P	Chief Executive Officer	옵션 행사 (매도)	20,000	$1.24	$24.8K	128,767
2021-08-18	Thorp Clay	Director	정보 매수	10,000	$3.00	$30K	32,943
2021-08-18	Hutson Nancy J	Director	정보 매수	3,000	$3.08	$9.24K	4,000
2021-08-18	Hutson Nancy J	Director	정보 매수	3,000	$3.08	$9.24K	4,000
2021-08-03	Sharp John P	Chief Financial Officer	RSU 부여	7,500	$1.68	$12.6K	50,224
2021-08-03	Sharp John P	Chief Financial Officer	옵션 행사	7,500	$1.68	$12.6K	50,224
2021-07-12	Arnold Susan Elizabeth	VP, Preclinical and Chem	옵션 행사 (매도)	4,519	$1.74	$7.86K	-
2021-07-12	Arnold Susan Elizabeth	VP, Preclinical and Chem	RSU 부여	4,519	$1.74	$7.86K	27,760